Irinotecan Hydrochloride Injection 500 mg

Irinotecan Hydrochloride Injection 500 mg is a cancer treatment medication used to slow or stop cancer cell growth. This intravenous solution is manufactured by Eugia Pharma Inc. in Canada.

Irinotecan Hydrochloride Injection is primarily used in cancer treatment, particularly for colorectal cancer. It works by interfering with the growth and spread of cancer cells. This medication is often used in combination with other treatments as part of a comprehensive cancer care plan.

Common effects of Irinotecan Hydrochloride Injection may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely among individuals.

Irinotecan Hydrochloride Injection should be handled with care and administered by healthcare professionals. It is important to follow all safety guidelines and precautions provided by your healthcare provider. This medication should be stored and used as directed to ensure safety and effectiveness.

Irinotecan Hydrochloride Injection may interact with other medications, including those that affect the liver or blood cell counts. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.